At-home STI test pulled from Australian shelves after failing to detect infections
Australia's Therapeutic Goods Administration pulled Touch Biotechnology's at-home chlamydia and gonorrhoea test from shelves after finding it unreliably detected infections. The company received a six-month suspension following reports of false negative results affecting an unspecified number of patients since the product's December 2024 launch.
How does this story land?
Summary by OZbrief Editorial · The Guardian Australia · Source
Take it further — get the full app and never miss a moment of what's happening in Australia.
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
Published 20 Jul 2026, 15:00 UTC · Updated 20 Jul 2026, 15:21 UTC
Summary by OZbrief Editorial. Original report: The Guardian Australia. Editorial policy · Corrections
Trending
- Perth traffic: Peak-hour chaos as police incident shuts Albany Highway
- Breaking: Terence Donovan dies aged 90
- ‘Everyone's afraid to die’: Struggle to recruit soldiers in Ukraine turns violent
- Salvation Army worker's medication error leads to resident's death
- Concerns for lost health services under sale to Calvary
- Wallabies player ratings: How the men in gold performed